Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time

Molecular Therapy

Volumn 8, Issue 2, 2003, Pages 284-294

  Ferrari, Aldo ^a   Pellegrini, Vittorio ^a   Arcangeli, Caterina ^a   Fittipaldi, Antonio ^a   Giacca, Mauro ^a,b   Beltram, Fabio ^a  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Caveolae; GFP; HIV 1; Protein transduction; Tat

Indexed keywords

ACTIN; CYTOCHALASIN D; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSPORT; CELL VACUOLE; CHEMOSENSITIVITY; CHO CELL; CONTROLLED STUDY; CYTOSKELETON; FLUORESCENCE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN TRANSPORT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0042355293     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00122-9     Document Type: Article

References (48)

1. Dingwall, C., et al. (1989). Human immunodeficiency virus 1 Tat protein binds transactivation-responsive region (TAR) in vitro. Proc. Natl Acad Sci. USA 86: 6925-6929.
2. Ensoli, B., Barillari, G., and Salahuddin, S. (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86.
3. Ensoli, B., et al. (1992). Release, uptake, and effects of extracellular human immuno-deficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67: 277-287.
4. Barillari, G., Gendelman, R., Gallo, R., and Ensoli, B. (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90: 7941-7945.
5. Flores, S. C., et al. (1993). Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90: 7632-7636.
6. Howcroft, T. K., Strebel, K., Martin, M. A., and Singer, D. S. (1993). Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320-1322.
7. Taylor, J. P., et al. (1992). Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc. Natl. Acad. Sci. USA 89: 9617-9621.
8. Westendorp, M., Li-Weber, M., Frank, R. W., and Krammer, P. H. (1994). Human immunodeficiency virus type 1 Tat upregulates interleukin 2 secretion in activated T cells. J. Virol. 68: 4177-4185.
9. Fawell, S., et al. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91: 664-668.
10. Schwarze, S. R., and Dowdy, S. F. (2000). In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21: 45-48.
11. Vivès, E., Brodin, P., and Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017.
12. Futaki, S., et al. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276: 5836-5840.
13. Schwarze, S. R., Hurska, K. A., and Dowdy, S. F. (2000). Protein transduction: unrestricted delivery into all cells. Trends Cell Biol. 10: 290-295.
14. Rusnati, M., et al. (1997). Interaction of HIV-1 Tat protein with heparin. J. Biol. Chem. 272: 11313-11320.
15. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001). Internalization of HIV-1 Tat requires cell surface heparin sulfate proteoglycans. J. Biol. Chem. 276: 3254-3261.
16. Leifert, J. A., Harkins, S., and Whitton, J. L. (2002). Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther. 9: 1422-1428.
17. Richard, J. P., et al. (2003). Cell penetrating peptides: a re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278: 585-590.
18. Seisenberger, G., Ried, M. U., Endreß, T., Büning, H., Hallek, M., and Bräuchle, C. (2001). Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. J. Biol. Chem. 294: 1929-1932.
19. Pelkmans, L., Kartenbeck, J., and Helenius, A. (2001). Caveolar endocytosis of simian virus SV40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3: 473-483.
20. Stehle, T., Yan, Y., Benjamin, T. L., and Harrison, S. C. (1994). Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369: 160-163.
21. Marjomaki, V., et al. (2002). Internalization of echovirus 1 in caveolae. J. Virol. 76: 1856-1865.
22. Ikonen, E., and Parton, R. G. (2000). Caveolins and cellular cholesterol balance. Traffic 1: 212-217.
23. Campbell, S. M., Crowe, S. M., and Mak, J. (2001). Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22: 217-227.
24. Montesano, R., Roth, J., Robert, A., and Orci, L. (1982). Non-coated membrane invaginations are involved in binding and invagination of cholera and tetanus toxins. Nature 296: 651-653.
25. Nichols, B. J., et al. (2001). Rapid cycling of lipid rafts between the cell surface and Golgi complex. J. Cell Biol. 153: 529-541.
26. Mundy, D., Machleidt, T., Ying, Y., Anderson, R. G., and Bloom, G. S. (2002). Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115: 4327-4339.
27. Thomsen, P., Roepstorff, K., Stahlhut, M., and van Deurs, B. (2002). Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell 13: 238-250.
28. Lippincot-Schwartz, J., and Smith, C. L. (1997). Insights into secretary and endocytic membrane traffic using green fluorescent protein chimeras. Curr. Opin. Neurobiol. 7: 631-6639.
29. Sieczkarski, S. B., and Whittaker, G. R. (2002). Dissecting virus entry via endocytosis. J. Gen. Virol. 83: 1535-1545.
30. Marzio, G., Tyagi, M., Gutierrez, M. I., and Giacca, M. (1998). HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 23: 13519-13524.
31. De Marchi, F., d'Adda di Fagagna, F., Falaschi, A., and Giacca, M. (1996). Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70: 4427-4437.
32. Caron, N. J., et al. (2001). Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol. Ther. 3: 310-318.
33. Wachter, R. N., and Remington, S. J. (1999). Sensitivity of the yellow variant of green fluorescent protein to halides and nitrate. Curr. Biol. 9: R628-629.
34. Cinelli, R., Ferrari, A., Pellegrini, V., Tyagi, M., Giacca, M., and Beltram, F. (2000). The enhanced green fluorescent protein as a tool for the analysis of protein dynamics and localization: local fluorescence study at the single-molecule level. Photochem. Photobiol. 71: 771-775.
35. Wacher, I., Kaether, C., Kromer, A., Migala, A., Almers, W., and Gerders, H-H. (1997). Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein. J. Cell Sci. 110: 1453-1463.
36. Fujimoto, T., Miyawaki, A., and Mikoshiba, K. (1995). Inositol 1,4,5-triphosphate receptor-like protein in plasmalemmal caveolae is linked to actin filaments. J. Cell Sci. 108: 7-15.
37. van Deurs, B., von Bulow, F., Vilhardt, F., Holm, P. K., and Sandvig, K. (1996). Destabilization of plasma membrane structure by prevention of actin polymerization. Microtubule-dependent tubulation of the plasma membrane. J. Cell Sci. 109: 1655-1665.
38. Frankel, A. D., and Pabo, C. O. (1988). Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
39. Mann, D. A., and Frankel, A. D. (1991). Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10: 1733-1739.
40. Fang, B., Xu, B., Koch, P., and Roth, J. A. (1998). Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther. 5: 1420-1424.
41. Pelkmans, L., and Helenius, A. (2002). Endocytosis via caveolae. Traffic 3: 311-320.
42. Pelkmans, L., Püntener, D., and Helenius, A. (2002). Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296: 535-539.
43. Fittipaldi, A., et al. (2003). Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem., in press.
44. Cheng, F., Mani, K., van den Born, J., Ding, K., Belting, M., and Fransson, L. (2002). Nitric oxide-dependent processing of heparin sulfates in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem. 277: 44431-44439.
45. Tumova, S., Woods, A., and Couchman, J. R. (2000). Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 32: 269-288.
46. Eguchi, A., et al. (2001). Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276: 26204-26210.
47. Bonifaci, N., Sitia, R., and Rubartelli, A. (1995). Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9: 995-1000.
48. Bender, F., Montoya, M., Monardes, V., Leyton, L., and Quest, A. F. (2002). Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35: 151-167.96